GRAFT POLYMER UK LS -001 Market Cap ($7.90 Million)
Market Cap & Net Worth: GRAFT POLYMER UK LS -001 (J4I)
GRAFT POLYMER UK LS -001 market cap. GRAFT POLYMER UK LS -001 (F:J4I) has a market capitalization of $7.90 Million (€6.76 Million) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #27511 globally and #2358 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying GRAFT POLYMER UK LS -001's stock price €0.00 by its total outstanding shares 7899736826 (7.90 Billion). Also see GRAFT POLYMER UK LS -001 cash conversion from operations for how efficiently the company converts equity into cash flow.
GRAFT POLYMER UK LS -001 Market Cap History (2022–2026)
GRAFT POLYMER UK LS -001 market cap history from 2022 to 2026. Data shows change from $1.30 Billion to $9.24 Million (-68.53% CAGR). Check GRAFT POLYMER UK LS -001 stock price for real-time trading data and today's change.
GRAFT POLYMER UK LS -001 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how GRAFT POLYMER UK LS -001's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore GRAFT POLYMER UK LS -001 (J4I) net asset momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
7.87x
GRAFT POLYMER UK LS -001's market cap is 7.87 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $4.62 Million | $542.00K | -$2.71 Million | 8.52x | N/A |
| 2024 | $4.62 Million | $587.00K | -$3.12 Million | 7.87x | N/A |
Competitor Companies of J4I by Market Capitalization
Companies near GRAFT POLYMER UK LS -001 in the global market cap rankings as of November 4, 2026. Also see J4I asset base for a full breakdown of the balance sheet.
Key companies related to GRAFT POLYMER UK LS -001 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #180 globally with a market cap of $130.90 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #372 globally with a market cap of $76.14 Billion USD.
- CSL Ltd (AU:CSL): Ranked #411 globally with a market cap of $69.05 Billion USD ( AU$97.59 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #497 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #180 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.90 Billion | $553.15 |
| #372 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $76.14 Billion | $961.26 |
| #411 | CSL Ltd | AU:CSL | $69.05 Billion | AU$201.16 |
| #497 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $220.83 |
Market Capitalization of GRAFT POLYMER UK LS -001 (2022–2026)
Market capitalization of GRAFT POLYMER UK LS -001 from 2022 to today. Between 2022 and today, GRAFT POLYMER UK LS -001's market cap moved from $1.30 Billion to $ 9.24 Million, with a yearly change of -68.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €9.24 Million | 0.00% |
| 2025 | €9.24 Million | +100.00% |
| 2024 | €4.62 Million | 0.00% |
| 2023 | €4.62 Million | -99.65% |
| 2022 | €1.30 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of GRAFT POLYMER UK LS -001 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $7.90 Million USD |
| MoneyControl | $7.90 Million USD |
| MarketWatch | $7.90 Million USD |
| marketcap.company | $7.90 Million USD |
| Reuters | $7.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About GRAFT POLYMER UK LS -001
Solvonis Therapeutics plc, a clinical-stage biopharmaceutical company, develops medicines for addiction, psychiatry, and neurology disorders. The company develops SVN-001, an NMDA receptor antagonist that is in Phase III clinical trial for the treatment of severe alcohol use disorder; and SVN-002, which has completed Phase I clinical trial to treat moderate to severe alcohol use disorder. Its pre… Read more